tirzepatide surpass trials versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial Flow of Participants in the

Taking semaglutide with other diabetes medicines like insulin or certain drugs like levothyroxine and warfarin can increase the risk of side effects

Note: the color is uniform top-to-bottom

Tirzepatide can produce dramatic results, with clinical trials showing average weight loss of 15 to 22 percent of body weight, but some of that loss comes from lean tissue rather than fat

Complete Your Assessment Online Provide insights on your weight goals, medical history, and current medications during an online consultation

Due to changes in your digestive system and how your body metabolizes drugs, you may need a lower dose than what's typically recommended on the packaging